L'Oréal Paris
$19.04 · Cleanser
Your profile match
Community
Not enough reports yet (0/3).
Ideal for
Not recommended for
Caution
May aggravate: Psoriasis (Sodium Laureth Sulfate)
Set up a profile to see which of these apply to you.
, buffing away dead skin cells to reveal radiance, while supporting a noticeably soft and supple finish. What’s more, the foaming cleanser melts away all impurities, makeup and excess oils, leaving the complexion prepped and ready for following skincare formulas.
☼ AM / ☽ PM Application: Massage a small amount on wet face. Rinse off with water. Routine: For even better results, complete your dark spot routine with our Bright Reveal Niacinamide Dark Spot Serum and Bright Reveal Dark Spot UV Fluid SPF 50+. Ingredient
Key actives
Aqua / Water, Sodium Laureth Sulfate, Glycerin, Decyl Glucoside, Coco-Betaine, Salicylic Acid, Sodium Chloride, Niacinamide, Zinc Pca, Peg-150 Pentaerythrityl Tetrastearate, Peg-6 Caprylic/Capric Glycerides, Sodium Hydroxide, Capryloyl Salicylic Acid, Tetrasodium Glutamate Diacetate, Citric Acid, Hexylene Glycol, Parfum / Fragrance (F.I.L. Z70039118/1). For the latest information, it is recommended to review the ingredient list printed on the packaging of the product prior to usage or consumption.
43 studies on 7of this product’s ingredients. These study the ingredient, not this product.
Dermatology and Therapy, 2015 · n=120 · systematic-review
Systematic review of keratolytics and emollients in psoriasis therapy: salicylic acid is a key keratolytic that removes psoriatic scale and improves penetration of co-applied topical agents; supports salicylic acid as an evidence-based adjunctive (descaling) treatment rather than a standalone therapy.
Clinical, Cosmetic and Investigational Dermatology, 2015 · systematic-review
Comprehensive review: salicylic acid (2%) is the only lipophilic BHA, enabling comedolytic and anti-inflammatory activity within the pilosebaceous unit; effective for acne vulgaris, melasma, photodamage, and keratosis pilaris; 20-30% SA peels show efficacy comparable to glycolic acid peels with lower erythema risk in Fitzpatrick IV-VI
Journal of the European Academy of Dermatology and Venereology, 2011 · n=50 · rct
Single-blind RCT (n=46, 12 weeks) in mild-to-moderate acne comparing salicylic acid 3% plus clindamycin with tretinoin 0.05% plus clindamycin: both significantly reduced inflammatory and non-inflammatory lesion counts; tretinoin acted faster (significant by week 2) but groups were comparable at 12 weeks, and both were well tolerated.
Used this product? Sign in to share your outcome and see what people with your skin reported.
Sign in to add your experienceNo reports yet. Be the first to share your experience.
Community outcomes are self-reported member experiences, shown separately from the evidence score — never blended into it. Educational, not medical advice.